CRIS Current Research Information System

GIONCHETTI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.854
EU - Europa 7.173
AS - Asia 2.443
AF - Africa 492
SA - Sud America 20
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 5
Totale 19.996
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.776
GB - Regno Unito 1.866
IT - Italia 1.355
SE - Svezia 1.046
DE - Germania 931
CN - Cina 847
VN - Vietnam 754
UA - Ucraina 424
IE - Irlanda 399
IN - India 391
FR - Francia 271
RU - Federazione Russa 238
SG - Singapore 228
TG - Togo 176
ZA - Sudafrica 142
CH - Svizzera 141
BG - Bulgaria 138
EE - Estonia 130
JO - Giordania 117
CI - Costa d'Avorio 116
FI - Finlandia 66
BE - Belgio 60
HN - Honduras 36
SC - Seychelles 36
IR - Iran 32
GR - Grecia 26
JP - Giappone 26
NL - Olanda 24
CA - Canada 22
NG - Nigeria 20
BZ - Belize 17
PL - Polonia 15
ES - Italia 10
AU - Australia 9
CL - Cile 8
CZ - Repubblica Ceca 8
RO - Romania 8
KR - Corea 7
HR - Croazia 6
LB - Libano 6
AR - Argentina 5
BR - Brasile 5
A2 - ???statistics.table.value.countryCode.A2??? 4
HK - Hong Kong 4
PH - Filippine 4
UZ - Uzbekistan 4
AT - Austria 3
IL - Israele 3
SA - Arabia Saudita 3
TR - Turchia 3
AG - Antigua e Barbuda 2
DK - Danimarca 2
MY - Malesia 2
NO - Norvegia 2
QA - Qatar 2
TW - Taiwan 2
VE - Venezuela 2
AF - Afghanistan, Repubblica islamica di 1
DZ - Algeria 1
EU - Europa 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
MU - Mauritius 1
MX - Messico 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 19.996
Salva come PNG Salva come JPEG
Città #
Southend 1.643
Fairfield 1.284
Chandler 1.062
Ashburn 907
Woodbridge 616
Wilmington 537
Seattle 536
Houston 527
Princeton 517
Dong Ket 444
Cambridge 419
Dublin 399
Ann Arbor 353
Jacksonville 242
Bologna 234
Nanjing 185
Lomé 176
Westminster 174
Berlin 171
Singapore 163
Padova 151
Sofia 134
Bern 122
Amman 117
Abidjan 116
San Diego 105
Milan 99
Beijing 87
New York 82
Saint Petersburg 76
Shenyang 74
Turin 71
Jinan 66
Brescia 65
Hebei 60
Changsha 57
Helsinki 52
Mülheim 51
Redwood City 50
Nanchang 47
Redmond 43
Boardman 41
Bremen 41
Medford 41
Brussels 40
Dearborn 36
Los Angeles 36
Phoenix 36
Rome 36
Henderson 34
Falls Church 33
Des Moines 32
Jiaxing 31
Washington 31
Mahé 29
Olalla 29
Tianjin 29
Centro 26
Florence 25
Norwalk 25
Haikou 24
Frankfurt am Main 23
Saint Louis 22
Brierley Hill 21
Guangzhou 20
London 19
Pune 19
Abeokuta 18
Leawood 18
Belize City 17
Taizhou 17
Tokyo 17
Verona 16
Zhengzhou 16
Atlanta 15
Boydton 15
Lanzhou 15
Ningbo 15
Pesaro 14
San Venanzo 14
Taiyuan 14
Bühl 13
Hangzhou 13
Lappeenranta 13
Toronto 13
Buffalo 12
Chicago 12
Modena 11
Provo 11
Capaccio 10
Castel Maggiore 10
Monmouth Junction 10
Parma 10
Cervia 9
Ferrara 9
Kunming 9
Paris 9
San Pedro Sula 9
Zwijnaarde 9
Amsterdam 8
Totale 13.514
Salva come PNG Salva come JPEG
Nome #
Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection 510
Ulcerative Colitis 203
Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil antibodies in coeliac disease before and after gluten free diet. 196
COVID-19 in IBD: The experience of a single tertiary IBD center 194
A-Transducin, a Signaling Molecule of the Chemoreceptive Cascade, Is Expressed in Endocrine and Non-Endocrine Cells of the Pig Gastrointestinal Mucosa 176
Adenocarcinoma in Crohn's disease: the pathologist's experience in a tertiary referral centre of inflammatory bowel disease. 174
Adalimumab in active ulcerative colitis: a "real-life" observational study. 165
Adult attachment and early parental experiences in patients with Crohn’s Disease 164
Attachment and quality of life in patients with inflammatory bowel disease 154
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 152
Management of pouch dysfunction or pouchitis with an ileoanal pouch. 151
Absence of change in the gray matter volume of patients with ulcerative colitis in remission: a voxel based morphometry study 151
Four cases of carcinoid tumour in Crohn's disease: coincidence or correlation? 146
Infliximab in the treatment of Crohn's disease 145
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: A SINGLE CENTER EXPERIENCE IN 64 PATIENTS 145
Can supplementation of phytoestrogens/insoluble fibers help the management of duodenal polyps in familial adenomatous polyposis? 144
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease 143
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations 143
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis 141
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management 136
Brain functional changes in patients with ulcerative colitis: a functional magnetic resonance imaging study on emotional processing 134
Clinical management of severe active ulcerative colitis in the TNF-α inhibitors era 134
Clinical course of microscopic colitis in a single-center cohort study 132
Performance of Capsule Endoscopy and Cross-Sectional Techniques in Detecting Small Bowel Lesions in Patients with Crohn’s Disease 132
MODULATION OF HUMAN DENDRITIC CELL PHENOTYPE AND FUNCTION BY PROBIOTIC BACTERIA 131
Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease 131
Management and treatment of distal ulcerative colitis 129
Short-term treatment with Infliximab in chronic refractory pouchitis and ileitis. 128
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. 127
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. 124
Cutaneous Manifestations in Inflammatory Bowel Diseases: Eight Cases of Psoriasis Induced by Anti-Tumor-Necrosis-Factor Antibody Therapy 124
Adalimumab in the Treatment of Perianal Crohn's Disease: A Single Center in 64 Patients 124
Frequency of NOD2/CARD15 variants in both sporadic and familial cases of Crohn's disease across Italy. An Italian Group for Inflammatory Bowel Disease Study. 123
Distinct proteomic profiles characterise non-erosive from erosive reflux disease. 123
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: LONG TERM RESULTS IN A SINGLE TERTIARY CENTRE 123
Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn's disease versus healthy controls 123
Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients. 121
Real-time elastography for the detection of fibrotic and inflammatory tissue in patients with stricturing Crohn's disease 120
High-dose probiotics for the treatment of active pouchitis 118
Medical treatment and management of severe ulcerative colitis 118
Antibiotics and probiotics in treatment of inflammatory bowel disease 118
Sympathetic hyperactivity in patients with ulcerative colitis. 117
Multidisciplinary management of patients with coexisting inflammatory bowel disease and spondyloarthritis: A Delphi consensus among Italian experts 117
Drug delivery by polymeric micelles: an in vitro and in vivo study to deliver lipophilic substances to colonocytes and selectively target inflamed colon 115
Antimicrobials in the management of inflammatory bowel disease 115
COMBINATION OF SURGICAL THERAPY AND LOCAL INJECTIONS OF ADALIMUMAB IN TREATEMENT OF COMPLEX PERIANAL CROHN'S DISEASE 114
Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production 112
Implications of antioxidant enzymes in human gastric neoplasms 112
Review article: aminosalicylates for distal colitis 111
Oral budesonide in the treatment of chronic refractory pouchitis. 111
CT-guided percutaneous pelvic abscess drainage in Crohn's disease 111
Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease 111
P325 Risk factors for lymph node involvement in patients undergoing ileal pouch-anal anastomosis for ulcerative colitis complicated by colorectal cancer in the biological years 110
P151 Characteristics of presentation and risk factors for early recurrence after strictureplasty for Crohn’s disease of the small bowel in the biological era 110
Role of conventional therapies in the era of biological treatment in Crohn's disease. 110
MANAGEMENT OF POUCHITIS 110
Sporadic small bowel tumors detected by capsule endoscopy in patients with occult gastrointestinal bleeding 109
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. 108
Oral beclomethasone dipropionate in chronic refractory pouchitis 108
Randomized controlled trials in pouchitis 108
Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study. 108
Local Injection of Infliximab for the Treatment of Perianal Crohn's Disease. 108
Which therapies are advisable in pouchitis? 106
Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis 106
Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease 105
Case-control Study on Dactylitis, Enthesitis, and Anterior Uveitis in Spondyloarthritis Associated with Inflammatory Bowel Diseases: Role of Coexistent Psoriasis 105
Problematic proctitis and distal colitis 105
The role of Budesonide-MMX in active ulcerative colitis. 104
Transabdominal salvage surgery after pouch failure in a tertiary center: a case-matched study 104
Probiotics, Prebiotics, and Antibiotics in IBD 101
Adalimumab in the treatment of immune-mediated diseases. 101
Probiotics in IBD: A critical review 101
Comparison of intestinal ultrasound, conventional enteroclysis, CT and MRI enteroclysis, surgical findings for determining complications in patients with Crohn's Disease 101
null 100
VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis 100
Role of Biologics in refractory pouchitis 100
New insights into the brain involvement in patients with Crohn's disease: a voxel-based morphometry study 100
Parental Bonding and Inflammatory Bowel Disease 100
Medical Treatment of Ulcerative Colitis: does traditional therapy still have a role? 100
Probiotic therapy to prevent pouchitis onset 99
Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease--an IG-IBD study. 98
Pre-pouch ileitis 98
Obscure gastrointestinal bleeding: single centre experience of capsule endoscopy. 98
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease 98
Management of inflammatory bowel disease: does rifaximin offer any promises 97
Local injection of adalimumab for perianal Crohn's disease: better than infliximab? 97
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 96
Predictors of early recurrence after strictureplasty for Crohn's disease of the small bowel during the years of biologics 96
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab. 95
Risks and Benefits of Mucosal Healing With Combined Immunosuppression in Paediatric Crohn's Disease: A Complex Topic That Needs Careful Evaluation 95
Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitis 95
Eviendep® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosis 95
null 93
Rescue therapy: ciclosporin or infliximab? 91
OC.01.8 USE OF INFLIXIMAB AND ADALIMUMAB IN REFRACTORY POUCHITIS 90
DOP62 Morbidity after primary ileocecal resection for Crohn’s disease in the years of biologics: Lesson learned over 631 patients exclusively treated in a tertiary centre 90
Highly concentrated probiotics prevent pouchitis onset 89
Parvovirus B19 infection localized in the intestinal mucosa and associated with severe inflammatory bowel disease 89
Clinical guidelines for the management of pouchitis 89
null 88
Totale 12.220
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.340
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.340
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.215 0 113 55 301 502 517 591 667 677 361 172 259
2020/20213.182 580 169 81 143 92 172 140 281 312 244 120 848
2021/20224.121 431 114 247 182 332 178 98 229 332 293 1.082 603
2022/20234.953 512 756 251 558 322 393 142 292 907 143 343 334
2023/20241.547 108 240 138 114 127 361 79 93 41 110 60 76
2024/2025308 297 11 0 0 0 0 0 0 0 0 0 0
Totale 20.792